Versant Ventures VI Gp-Gp, LLC
CIK 0001777652
10% Owner
Filings
21
Latest Oct 2, 2025
Issuers covered
8
Showing
21 of 21
Page 1
Track record
43 of 56 open-market trades scored (77% price coverage) - 13 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 43 | 42% | +3.6% | -3.1% | +34.6% | -44.2% |
| 90 days | 43 | 74% | +21.4% | +30.0% | +64.5% | -51.8% |
| 180 days | 43 | 93% | +55.9% | +68.1% | +82.2% | -9.2% |
| 365 days | 9 | 44% | +1.7% | -0.8% | +57.7% | -33.4% |
Issuers
Companies where Versant Ventures VI Gp-Gp, LLC has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| GRPH | Graphite Bio, Inc. | 9 | Oct 2, 2025 |
| GLUE | Monte Rosa Therapeutics, Inc. | 3 | Oct 30, 2024 |
| LVTX | Lava Therapeutics NV | 2 | Sep 23, 2025 |
| OYST | Oyster Point Pharma, Inc. | 2 | Jan 4, 2023 |
| TPST | Tempest Therapeutics, Inc. | 2 | Aug 12, 2024 |
| IPSC | Century Therapeutics, Inc. | 1 | Feb 2, 2022 |
| CTNM | Contineum Therapeutics, Inc. | 1 | Apr 11, 2024 |
| RPTX | Repare Therapeutics Inc. | 1 | Jun 7, 2022 |
All filings
21 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|